Harvard Business Review

OCTOBER 26, 2017

Today when we talk about business “ clusters ,” we’re usually talking about the technology industry in Silicon Valley, the financial sector in London or New York, or automakers in southern Germany. The innovation of the Bolognese silk makers was to operate the Lucca machine with a hydraulic wheel, instead of by hand.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

JANUARY 5, 2018

In sales-driven companies (think pharmaceuticals and industrial equipment), they are often field sales managers who direct dozens of salespeople in the highest-volume regions. These are jobs in R&D, technology, and other areas vital to a firm’s strategic direction, product development, and process efficiency.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. Operating in a Global Marketplace. Eight of the CEOs pointed to the challenges of operating in a fast-paced global marketplace. As a pharmaceutical company, we obviously were part of that whole ecosystem.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

APRIL 15, 2015

By 1973, there were 3,000 industrial robots in operation. million industrial robots are in use or available in various industries including automotive, electronics, rubber and plastics, cosmetics, pharmaceutical, and food and beverage. Technology' It was precise, but not necessarily elegant. By 2003, there were 800,000.

Definition 8

Definition Ethics Industry Automotive 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. The technology world has some harrowing examples that no innovation-based industry should ever forget. billion tender offer directly to shareholders.

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

NOVEMBER 24, 2015

The most common source of joint value is economies of scale , which allow for a reduction in the costs of either production or back-office operations. To make a combination successful, you need to engineer the economies of scale carefully to target the potential source of joint value.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. To best leverage worldwide creative talent, Reliance MediaWorks operates a global network of creative centers located in Burbank, San Francisco, London, Tokyo, and across India. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JANUARY 31, 2013

Increasingly, customers demand more after-sale service; this is the norm now in business-to-business sales, but will spill over to consumer goods, too, thanks to some of the technology advances we'll talk about below. All over the world, automakers are mastering new drive train technologies.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

JULY 16, 2013

And 43% cited technology expertise, HR-talent management, international-global expertise, and succession planning as the skills missing most on their boards. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., We also looked at results by industry and region.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

FEBRUARY 20, 2014

You can read about it in recent issues of The Economist , The New York Times , and in the book The Second Machine Age by Erik Brynjolfsson and Andrew McAfee of the Massachusetts Institute of Technology. The arguments are familiar. Today, there are 116 million people employed in the service sector, according to the Bureau of Labor Statistics.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. Engineering. These may involve new areas for the company (e.g.,

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

JULY 12, 2011

Long term commitment in a world where the technology is advancing almost on a daily basis is difficult to maintain. Boston Scientific a few years back launched a secret project to reverse-engineer the technology of its single-source supplier of coronary stents. Judge McVeigh's punch line applies across a range of industries.

Management 11

Management Airlines How To Pharmaceuticals 11

Harvard Business Review

SEPTEMBER 20, 2011

economy as a whole, rather than the narrow, specific slices of technology or communication, the first decade of the 21st century did not generate expected growth in jobs, revenues, profits, or stock prices. The business press puts a tremendous focus on technology and innovation, but what it doesn't do is put it into context.

Innovation 12

Innovation Supply Chain Offshoring Policies 12

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. and technological uncertainty (can we make a desirable solution?) Technological uncertainty results from unknowns regarding the technologies that might emerge or be combined to create a new solution.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. Sponsored by DXC Technology. Insight Center.

Innovation 13

Innovation Productivity Products Venture Capitalist 13